US doubles spending on potential coronavirus vaccine to nearly US$1 billion

📆 7/27/2020 12:00 AM
📰 The Straits Times

⏱ Reading Time:
26 sec. here
2 min. at publisher
📊 Quality Score:
News: 14%
Publisher: 63%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

WASHINGTON (AFP) - The United States has doubled its investment - to nearly US$1 billion (S$1.38 billion) - to expedite development of a potential Covid-19 vaccine by American firm Moderna, which on Monday (July 27) begins the decisive final phase of clinical trials.. Read more at straitstimes.com.

WASHINGTON - The United States has doubled its investment - to nearly US$1 billion - to expedite development of a potential Covid-19 vaccine by American firm Moderna, which on Monday begins the decisive final phase of clinical trials.

In a small, initial trial, Moderna's experimental vaccine produced coronavirus antibodies - which should help fend off the disease - in the bodies of all 45 participants. It has announced massive investments in a huge effort to expedite vaccine development and get millions of Americans vaccinated by early next year.

Moderna, which has been working with US health authorities, said it expects to be able to produce 500 million doses a year - and potentially up to 1 billion - starting in 2021.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Finance Finance Latest News, Finance Finance Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US: Stocks fall amid rising China tensions[NEW YORK] Wall Street stocks fell for a second session in a row Friday on rising US-China tensions and worries that equities have gotten overvalued. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »